Serina Therapeutics, Inc. ( SER) - Stock Earnings
SER Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 7, 2026, midnight | — / — | — | — / — | — |
SER Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.6 million USD | — USD |
| 2025Q4 | -3.3 million USD | — USD |
| 2026Q1 | -6.9 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SER Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 5.3 million USD | 3.2 million USD |
| 2024 | -11.1 million USD | 56000 USD |
| 2025 | -19.2 million USD | 130000 USD |
| 2026 Est. | — | — |
SER
Price: $2.09
52 week price:
Earnings Per Share: -2.00 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 20.6 million